United States: OIG Issues New Exclusion and CIA Guidance


On April 18, 2016, Inspector General Daniel R. Levinson announced the publication of updated guidance on how the Office of Inspector General (OIG) makes decisions about using its permissive exclusion authority and requiring integrity obligations when presented with a False Claims Act (FCA) settlement. This document is noteworthy not only to defendants in FCA cases but also to the health care industry in evaluating their compliance program activities.

In Depth

On April 18, 2016, Inspector General Daniel R. Levinson announced the publication of updated guidance on how the Office of Inspector General (OIG) makes decisions about using its permissive exclusion authority and requiring integrity obligations when presented with a False Claims Act (FCA) settlement. This document is noteworthy not only to defendants in FCA cases but also to the health care industry in evaluating their compliance program activities.

Section 1128(b)(7) Exclusion Authority

The permissive exclusion authority at issue, Section 1128(b)(7) of the Social Security Act (42 USC 1320a-7(b)(7)), is the authority that permits OIG to bring an exclusion action for conduct that could also be pursued under the FCA—namely false or fraudulent claims or anti-kickback or Stark law issues. Negotiating the resolution of OIG's 1128(b)(7) authority is generally part of the settlement process of FCA cases and formed the basis for why OIG developed corporate integrity agreements (CIAs) more than 20 years ago.

1997 OIG Guidance

OIG first issued guidance on the 1128(b)(7) authority in 1997, but the updated guidance is structured much differently than the 1997 notice. While both retain the "presumption" that a person would has defrauded the federal health care programs should be excluded, the 1997 notice contained general factors on how OIG made exclusion and CIA decisions but provided few clues on how the factors were valued against each other. The 1997 notice also only dealt with the binary decision between exclusion or CIA. Over time, this came to not reflect OIG's development of other options, such as "unilateral monitoring" by OIG or OIG choosing to not seek a CIA in certain cases and "reserving" the 1128(b)(7) authority by not providing a release in the settlement agreement. Further, OIG's elevated the importance of self-disclosure in the 2008 Open Letter and 2013 updated OIG Self-Disclosure Protocol, which created a "presumption" of not requiring integrity obligations in resolving self-disclosures, was not reflected in the 1997 notice.

New Guidance Summary

The new guidance articulates, for the first time, OIG's risk assessment "continuum" and all of the options OIG considers in evaluating individuals and entities along this continuum. These options are, in order of high-to-low risk: exclusion; "heightened scrutiny" which includes OIG's own monitoring efforts or referrals to CMS or CMS' contractors; a CIA; "reserving" the 1128(b)(7) authority with no further action; and, finally, releasing the 1128(b)(7) authority when the person self-disclosed the matter. The OIG explains in some detail the reasons it chooses among these options. For example, OIG explains that there are two reasons why it may decide to not seek a CIA in an FCA settlement and reserve its exclusion authority: 1) the absence of egregious conduct such as patient harm, intentional fraud or relatively low financial harm in proportion to the size of the provider; or 2) there is a successor owner of the provider. In deciding whether to require a CIA of the successor owner, OIG considers whether the new owner: 1) purchased the entity after the subject conduct occurred; 2) has a compliance program; 3) does not have a history of "wrongdoing or fraud settlements" with the United States; 4) took appropriate steps to address the predecessor's misconduct and reduce the risk of future misconduct; and 5) can demonstrate other facts and circumstances relevant to the OIG's decision-making.

The new guidance then discusses four broad categories of factors that OIG considers in making a risk assessment: nature and circumstances of the conduct, conduct during the investigation, significant ameliorative efforts and history of compliance. While the OIG states that it is making an assessment of future risk of participation in federal health care programs, the factors OIG uses to make this assessment mostly deal with past conduct, especially the alleged past conduct that the defendant is settling in the FCA case. The most future-oriented factor, "significant ameliorative efforts," is limited to whether appropriate disciplinary action was taken against responsible individuals; whether the entity devoted "significantly more resources to the compliance function" (presumably after the investigation began); or whether entity was sold to a third party or a licensed individual received additional training and mentorship.

Defense and Compliance Lessons

OIG has signaled a significant shift in its assessment of when it seeks a CIA in an FCA settlement with this new guidance. The greater transparency in this document as to OIG's decision making and priorities should prove helpful for defense lawyers in structuring their negotiations with OIG on the CIA issue.

With this new guidance, OIG is sending a broader message to the health care industry than to just FCA defendants. When the 1997 guidance was issued, the state of compliance programs was in its infancy. So, OIG's guidance was set up at that time to give credit to the rare provider that had begun the process of setting up a compliance program, even if the impetus for doing so was the government investigation that the provider was settling. Over the past 20 years, compliance programs have become universal among the health care sector, in no small part due to OIG's focus on encouraging providers to create and maintain compliance programs.

In 2016, having a compliance program is the expectation of the OIG, as well as US Department of Justice, Centers for Medicare & Medicaid Services, and potential buyers, investors and lenders. Inspector General Levinson summed up the agency's attitude when announcing the guidance as there are "no bonus points for having a compliance program." At this point, OIG's goal has shifted from encouraging the creation of compliance programs to encouraging the operation of effective compliance programs. To OIG, effectiveness is measured in two ways: prevention and self-disclosure. When OIG faces a defendant in an FCA case, it believes that the compliance program may need further development and attention that a CIA would provide. For OIG "the goals of CIAs are to strengthen a person's compliance program and promote compliance so that future issues can be prevented or identified, reported, and corrected"—before the relator's complaint is filed.

OIG Issues New Exclusion and CIA Guidance

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.